16:14 EDT Processa Pharmaceuticals files $50M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCSA:
- Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
- Processa Pharmaceuticals appoints Steven Cha as SVP, clinical research
- Monster downgraded, Five Below upgraded: Wall Street’s top analyst calls
- Processa Pharmaceuticals initiated with a Buy at H.C. Wainwright
- Processa presents two abstracts at AACR 2024 including data on NGC-Cap trial
